Our research highlights
-
Breath-taking discoveries: the relationship between COVID-19 and the diaphragm
Researchers from the Intensive Care Medicine and Physiology departments were the first in the world to show that diaphragm muscle fibers possess the required receptors for the corona virus and that virus particles invaded the diaphragm muscle fibers.
Amsterdam Cardiovascular SciencesOngoing
-
Trombosis & COVID-19: addressing thrombosis-specific questions in COVID-19 patients
Researchers of the Vascular Medicine department were one of the first to publish about the risk of venous thromboembolism (VTE) in COVID-19 patients.
Amsterdam Cardiovascular SciencesOngoing
-
Severe COVID-19: Is complement the way out?
International phase III trial targeting the complement system to treat severe COVID-19.
Amsterdam Cardiovascular SciencesOngoing
-
CounterCOVID study: oral imatinib to prevent pulmonary vascular leak in COVID-19
Translational COVID-19 research that has led to clinical application of imatinib with the potential of a global impact.
Amsterdam Cardiovascular SciencesOngoing
-
Marfan Syndrome patient involvement in ACS research
With the help of Marfan patients and their families, researchers at the Medical Biochemistry and Clinical Genetics departments are able to study novel ways to treat Marfan syndrome and its symptoms.
Amsterdam Cardiovascular SciencesOngoing
-
Patient involvement in ACS research
Two heart patients who are passionately committed to the involvement of patients in cardiovascular research at Amsterdam UMC and beyond.
Amsterdam Cardiovascular SciencesOngoing
-
HEART (Hogeschool van Amsterdam En Amsterdam UMC Research Team): Ten years of interdisciplinary research collaboration
The Amsterdam UMC Heart Center has developed a successful research collaboration with the Amsterdam University of Applied Science, Faculty of Health.
Amsterdam Cardiovascular SciencesOngoing
-
Understanding the pathophysiology of osteochondral defects in the ankle from a basic science perspective
Most osteochondral defects (OCD) have a traumatic origin. The pathogenesis between a trauma to the development of an OCD remains unknown.
Ongoing
-
Stopping the progression of MS
Why do people with MS continue to deteriorate? How can disease progression be stopped? The researchers at the MS Center Amsterdam want to find answers to these questions.
Ongoing
-
New, rational therapy decisions for developmental brain disorders
The NWA supported NewTDec* consortium takes on the challenge to inform, perform and monitor rational treatments at the patient ‘N-of-1’ level.
Ongoing